Alpha 2.0
Login Register
» Articles » PMID: 6299919

Clonidine and GH Secretion in Insulin Dependent Diabetes (IDD)

Overview
Journal Horm Metab Res
Specialty Endocrinology
Date 1983 Jan 1
PMID 6299919
Citations 4
Authors
G Speroni
G P Ceda
L Capretti
G Valenti
Affiliations
Soon will be listed here.
Citing Articles

The effects of a specific growth hormone antagonist on overnight insulin requirements and insulin sensitivity in young adults with Type 1 diabetes mellitus.

Williams R, Amin R, Shojaee-Moradie F, Umpleby A, Acerini C, Dunger D Diabetologia. 2003; 46(9):1203-10.

PMID: 12898010 DOI: 10.1007/s00125-003-1175-8.

Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications.

Muller E, Rolla M, Ghigo E, Belliti D, Arvat E, Andreoni A Drugs. 1995; 50(5):805-37.

PMID: 8586028 DOI: 10.2165/00003495-199550050-00004.

Clinical and pharmacological characterization of anomalous metoclopramide-induced growth hormone secretion in insulin-dependent diabetes mellitus.

Caviezel F, Lepore G, Maglio M, Croci M, Comi G, Morricone L Acta Diabetol Lat. 1989; 26(2):133-45.

PMID: 2781979 DOI: 10.1007/BF02581365.

Inappropriate growth-hormone (GH) response to thyrotropin-releasing hormone (TRH) occurs infrequently in well-regulated diabetes mellitus.

Giampietro O, Ferdeghini M, Miccoli R, Gregori G, Penno G, Bertoli S Acta Diabetol Lat. 1990; 27(2):119-27.

PMID: 2116057 DOI: 10.1007/BF02581284.